NEWSROOM

NASDAQ

BranchOut Food Inc. Secures Third EnWave Dehydration Machine; Announces $40M Production Capacity with New Peru Facility

BranchOut Food Inc. Secures Third EnWave Dehydration Machine; Announces $40M Production Capacity with New Peru Facility

May 24, 2024

BEND, Ore., May 24, 2024 - BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced the expansion of its agreement with EnWave Corporation (TSX-V: ENW | FSE: E4U). As part of this enhanced partnership, BranchOut has purchased its third large-scale EnWave dehydration machine. This addition is strategically aimed at expanding its new facility in Peru, with operations anticipated to commence in Q3,...

Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog

Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog

May 23, 2024

- Record net sales for fiscal year 2024 increased 31% - - Net income increased 127% year over year – -Provides Q1 and Full Fiscal Year 2025 Revenue Guidance – -Backlog Increased to Year-over-Year Record High – -Conference Call Thursday, May 23, 2024 at 9:30am EST – MILTON, NY, May 23, 2024 – Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for its fourth quarter and fiscal year 2024, ended February 29,...

Following Guidance from U.S. Food & Drug Administration in Type-C Meeting Lipella Pharmaceuticals to Advance Lead Product Candidate to Phase 2b

Following Guidance from U.S. Food & Drug Administration in Type-C Meeting Lipella Pharmaceuticals to Advance Lead Product Candidate to Phase 2b

May 21, 2024

Share: Company to initiate Phase 2b clinical trial in lead asset, LP-10 in 2H 2024 Pittsburgh, PA, May 21, 2024 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company, announced today the receipt of U.S. Food & Drug Administration (“FDA”) Type-C meeting guidance regarding the LP-10 (liposomal tacrolimus) clinical program. Lipella expects to initiate a Phase 2b clinical trial evaluating LP-10 as a treatment for hemorrhagic...

Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog

Sono-Tek Announces Year-End FY 2024 Earnings Conference Call

May 20, 2024

Conference Call on Thursday, May 23, 2024, at 9:30 am ET MILTON, NY, May 20, 2024 – Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that the Company will hold a conference call to discuss its year-end fiscal year 2024 financial results, ended February 29, 2024, on Thursday, May 23, 2024 at 9:30 am ET. The year-end FY 2024 financial results press release will be issued before the market opens on May 23, 2024. Conference...

Blackboxstocks Files Form S-4 for Evtec Acquisition

Blackboxstocks Files Form S-4 for Evtec Acquisition

May 16, 2024

Reports First Quarter Financial Results for Fintech Operations Dallas, TX, May 16, 2024 – Blackboxstocks Inc. (NASDAQ: BLBX) (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, announced that it filed its Form S-4 on May 13, 2024, for its acquisition of Evtec Aluminium Ltd. and today reported its financial results for the first quarter ended March 31, 2024. The filing of the...

ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

May 15, 2024

Conference Call on Wednesday, May 15, 2024, at 1:30 p.m. PT / 4:30 p.m. ET IRVINE, CA, May 15, 2024 - Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, today reported financial results for the quarter ended March 31, 2024. Recent Highlights Announced global commercialization partnership with Bio-Rad Laboratories, Inc. On track to ship research use only (RUO) GraftAssureTM transplant monitoring test kits to initial customers in Asia, the U.S., and the EU in 2Q 2024. IVD...

BranchOut Food Inc. Announces Record First Quarter 2024 Results, Gross Margin Increased to 19%, On Track for ~$8M Run Rate

BranchOut Food Inc. Announces Record First Quarter 2024 Results, Gross Margin Increased to 19%, On Track for ~$8M Run Rate

May 15, 2024

Achieved a 1,407% revenue increase to $1.47 million in Q1 2024. Increased gross margin to 19% in Q1 2024, up from -3% last year. Secured $8 million in recurring revenue plus $1.1 million in rotational retailer commitments. BEND, Ore., May 15, 2024 - PRISM MediaWire - BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced its recent accomplishments and financial results for the first quarter ended March...

SKYX Reports Record First Quarter Sales of $19.0 Million Compared to $18.6 Million for First Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products

May 14, 2024

MIAMI, FL, May 14, 2024 - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies") (the “Company” or “SKYX”), a highly disruptive platform technology company with over 90 pending and issued patents globally and over 60 lighting and home décor websites, with a mission to make homes and buildings become safe and smart as the new standard, today reported its financial and operational results for the first quarter ended March 31, 2024. First Quarter 2024 and Recent Subsequent Achievements Generated...

BranchOut Food Inc. Announces Record First Quarter 2024 Results, Gross Margin Increased to 19%, On Track for ~$8M Run Rate

BranchOut Food Secures Large Scale Production Facility in Peru Capable of $40M in Production Capacity; Estimated 40-50% Gross Margins

May 14, 2024

Build out to begin immediately, with production expected to commence in the third quarter BEND, Ore., May 14, 2024 - BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, today announced that it has signed a long term lease for a 50,000 square foot production facility in Peru. Under the terms of the agreement, BranchOut Food has the first right to purchase the facility at a fixed price at any point during the...

ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

Oncocyte to Announce First Quarter 2024 Financial Results

May 13, 2024

Conference Call and Webcast on Wednesday, May 15, 2024 at 1:30 p.m. PT / 4:30 p.m. ET IRVINE, CA, May 13, 2024 - Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, announced today that the company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, after U.S. market close. The company will host a conference call and webcast on Wednesday, May 15, 2024, at 4:30 p.m. Eastern Time to discuss its financial results and highlights. Interested parties...

SKYX Announces First Quarter 2024 Corporate Update Call

May 9, 2024

Company to Present First Quarter 2024 Financial Results; Conference Call to be held on Tuesday, May 14 at 4:30 p.m. Eastern Time MIAMI, FL, May 09, 2024 - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive platform technology company with over 90 pending and issued patents globally, and over 60 lighting and home décor websites with a mission to make homes and buildings become safe-advanced and smart as the new standard, announced today that it will host a corporate update...

Potencial de desarrollo de la Industria del Litio

May 7, 2024

New York City, 7 de mayo de 2024 Potencial de desarrollo de la Industria del Litio Obtenga el nuevo informe sin costo El equipo de Vostock Capital ha preparado un informe basado en una encuesta realizada a los +400 participantes en el Congreso Litio America latina 2023, entre los participantes encuestados: personal de los ministerios de minas y energías de América Latina, periodistas de minería, altos ejecutivos de las empresas mineras de Litio, gerentes de las empresas proveedoras de la...

Development Potential of the Lithium Industry

May 7, 2024

New York City, May 07, 2024 Development Potential of the Lithium Industry Get the new report for free The Vostock Capital team has prepared a report based on a survey carried out at the Lithium Latin America 2023 Congress about the development potential of the lithium industry. The survey was conducted among governmental authorities, leading industry companies, mining association presidents, mining journalists, and industry providers, which will cover: LATAM countries with the most favorable...

SKYX to be a Main Event at TheRealDeal New York City Real-Estate Forum & Developer Showcase

May 7, 2024

As SKYX Continues to Enhance its Market Penetration in the US and Canada it Will Showcase its Patented Game-Changing Smart Home Platform Technologies with High-End Real-Estate Developers and Industry Professionals MIAMI, FL, May 07, 2024 - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), (the "Company" or "SKYX"), a highly disruptive platform technology company with over 90 pending and issued patents globally, and over 60 lighting and home décor websites with a mission to make homes and...

PRISM Q&A CORNER – Ashlee Vogenthaler , Markets Editor, PRISM MarketView

May 1, 2024

Decoding Market Dynamics: An Interview with Ashlee Vogenthaler, PRISM MarketView’s Markets Editor New York, May 01, 2024 - At PRISM MarketView we are proud to feature Ashlee Vogenthaler as our Markets Editor. Ashlee combines a deep understanding of finance and economics with a passion for writing, offering our readers insightful analyses and engaging commentary. Influenced early on by her mother’s finance career and an inspiring high school class, Ashlee developed a keen interest in the stock...

PRISM MarketView – Weekly Market Report – April 26, 2024

PRISM MarketView – Weekly Market Report – April 26, 2024

Apr 26, 2024

PRISM Market Pulse: Equities Rally Amid Mixed Big Tech Earnings; Economic Shifts and Sector-Specific Highlights New York, N.Y., April 26, 2024 - PRISM MarketView - Equities were higher through the morning into midday trading as the S&P 500 and Nasdaq are set to snap their three- and four-week losing streaks. Big tech was the topic of Street-talk this week as some of the Magnificent Seven reported earnings. The reports produced mixed and opposite reactions by the Street as Tesla (TSLA)...

SKYX Collaborates with World Leading Chinese Lighting Supplier and Manufacturer for the US, Chinese, and European Markets as it Continues to Enhance its Market Penetration

Apr 25, 2024

The Collaboration will Include SKYX’s Advanced and Smart Products to Both Professional and Retail Markets The Collaboration Agreement Provides SKYX Substantial Backing in Several Areas Including Financial, Mass Production Manufacturing Capabilities, and Distribution to Global Markets MIAMI, FL, April 25, 2024 - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), (the "Company" or "SKYX"), a highly disruptive smart platform technology company with more than 90 issued and pending patents...

BranchOut Food Inc. Announces Record First Quarter 2024 Results, Gross Margin Increased to 19%, On Track for ~$8M Run Rate

BranchOut Food Announces Third Contract with Nation’s Largest Retailer, to Total $8M in Annualized Revenue

Apr 24, 2024

New commitment valued at $300,000 brings total annualized value to over $8M BranchOut Food’s dried fruit products expected to enter 1,400 stores in September 2024 BEND, Ore., April 24, 2024 - BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, today announced it has expanded its existing relationship with the nation’s largest retailer. The new agreement brings the total annualized value of commitments from the...

PRISM MarketView – Biotech Breakfast

PRISM MarketView – Biotech Breakfast

Apr 22, 2024

Roche’s Alecensa Gets FDA Green Light; ImmunityBio Gains as PDUFA Date Approaches for Bladder Cancer Drug; Key Drug Trial Failures in 2024 New York, N.Y., April 22, 2024 - PRISM MarketView - Healthcare equities finished mostly higher after a very quiet trading session on Friday. The S&P 500 Healthcare Index closed up +0.32% versus the S&P 500 Index which lost (0.88%) and the XBI settled down (0.78%). A lack of momentum today left Roche stock up by just +0.95% following the FDA greenlit...

PRISM MarketView – Weekly Market Report

PRISM MarketView – Weekly Market Report

Apr 19, 2024

PRISM Market Pulse: Market Tumbles Amid Fed's Rate Stance; Mixed Corporate Earnings Highlight Sector Struggles New York, N.Y., April 19, 2024 - PRISM MarketView - Equities were down in the morning and into midday as the major indices remain on track to notch their third straight week of declines. Fedspeak continues to support the “higher-for-longer” narrative with no urgency to cut rates which has created further sharp outflows and investor skepticism. The Street has taken investors’ pulses in...

PRISM MarketView – Bio Investor Alert

PRISM MarketView – Bio Investor Alert

Apr 18, 2024

New York, N.Y., April 18, 2024 - PRISM MarketView - More than 83,000 new cases of bladder cancer are diagnosed in the US each year, and the illness is responsible for around 17,000 deaths annually. Urothelial carcinoma accounts for 90% of bladder cancers in the US and western Europe, and surgery, followed by chemotherapy or radiation is the current standard of care. There are 24 drugs approved by the FDA for bladder cancer, but due to invasive and life-changing surgical procedures, researchers...

Following Guidance from U.S. Food & Drug Administration in Type-C Meeting Lipella Pharmaceuticals to Advance Lead Product Candidate to Phase 2b

Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise

Apr 17, 2024

The new oncology committee will include: Jason Hafron, MD, DDS, PhD, MPH; and Pradeep Tyagi, PhD, MBA Pittsburgh, PA, April 17, 2024 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company, today announced the expansion of its Scientific Advisory Board to include oncology expertise. The new committee members are: Jason Hafron, MD, DDS, PhD, MPH, the Chief Medical Officer at Michigan Institute of Urology, and Professor of Urology at the...

BranchOut Food Inc. Announces Record First Quarter 2024 Results, Gross Margin Increased to 19%, On Track for ~$8M Run Rate

BranchOut Food Strengthens Financial Position with Successful Sale of Senior Secured Promissory Notes and Warrants

Apr 17, 2024

Transaction supports Company’s continued execution of its product roadmap and capital expenditures for new equipment BEND, Ore., April 17, 2024 - BranchOut Food Inc. (NASDAQ: BOF), a food technology company and maker of dehydrated fruit and vegetable-based products, today announced that it has completed the sale of $225,000 of Senior Secured Promissory Notes ("Notes") and Warrants to purchase an aggregate of 56,250 shares of the Company’s common stock. Each Warrant is exercisable for a...

AMPG Files For Shelf Registration To Replace Expired Identical Shelf Without Dilution, Reinforcing Financial Stability

AMPG Files For Shelf Registration To Replace Expired Identical Shelf Without Dilution, Reinforcing Financial Stability

Apr 16, 2024

HAUPPAUGE, NY, April 16, 2024 - AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G systems, and a global distributor of packages and lids for integrated circuit assembly, today announced it has filed with SEC a shelf registration statement on Form S-3 replacing the previous shelf registration which just expired. Once...

PRISM MarketView – Biotech Breakfast

Apr 15, 2024

Mobile-Health Network Solutions (MNDR) IPOs; Q32 Bio Surges; EMA Concludes GLP-1 Drugs Not Associated with Suicidal Thoughts New York, N.Y., April 15, 2024 - PRISM MarketView - Healthcare equities finished lower on Friday, in line with broad declines across the market. The S&P 500 Healthcare Index closed down (1.52%) versus the S&P 500 Index which lost (1.46%) and the XBI settled down (3.43%). The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee concluded...

ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

ONCOCYTE REPORTS Full Year 2023 FINANCIAL RESULTS

Apr 12, 2024

Conference Call on Friday, April 12, 2024 at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA, April 12, 2024 - Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the year ended December 31, 2023. Recent Highlights Bio-Rad Laboratories, Inc. commercial partnership for transplant monitoring IP $15.8 million in gross proceeds received from private placement offering $4.4 million and $3.8 million Q4 2023 and est. Q1 2024 cash burn, respectively...

ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

Apr 11, 2024

IRVINE, CA, April 11, 2024 - Oncocyte Corporation (NASDAQ: OCX), (“Oncocyte” or the “Company”), a precision diagnostics company, today announced that it has entered into definitive securities purchase agreements (the “Purchase Agreements”) for the purchase and sale of an aggregate of 5,077,387 shares of common stock, at a purchase price of $ 2.9164 per share of common stock, and pre-funded warrants to purchase 342,888 shares of common stock at a purchase price of $2.9163 per pre-funded warrant...

ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

Apr 11, 2024

- Bio-Rad expects to make equity investment in support of deal - Agreement provides for global exclusivity in transplant monitoring commercialization - Bio-Rad granted subsequent investment option upon FDA clearance IRVINE, CA, April 11, 2024 - Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, today announced a partnership agreement with Bio-Rad Laboratories (NYSE: BIO), a global leader in life science research and clinical diagnostics products, for the...

ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

ONCOCYTE TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS 

Apr 9, 2024

Conference Call and Webcast on Friday, April 12, 2024, at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA, April 09, 2024 - Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, announced today that the company will release its fourth quarter and full year 2023 financial results on Friday, April 12, 2024, prior to the U.S. market open. The company will host a conference call and webcast on Friday, April 12, 2024, at 5:00 a.m. Pacific Time / 8:00 a.m. Eastern Time to discuss its financial...

Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog

Sono-Tek Announces Preliminary Net Sales for Q4 and FY2024 and Provides Preliminary Sales Guidance for Q1 FY2025 and FY2025

Apr 8, 2024

12-Month Net Sales Reached ~$19.7 million, Gain of ~31% for FY2024 ended Feb 29, 2024 Q4 Net Sales Grew ~30% YOY; Backlog Grew ~7% YOY and Remains Strong Strong Sales Projected for Q1 FY2025 MILTON, NY, April 08, 2024 – Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced preliminary net sales and backlog for the fourth quarter of fiscal year 2024, ended February 29, 2024, and for the full fiscal year. Preliminary net sales...